Production (Stage)
Assembly Biosciences, Inc.
ASMB
$13.52
-$0.04-0.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 14.68% | -7.51% | 13.80% | -22.86% | 17.20% |
| Total Depreciation and Amortization | 3.13% | -3.03% | 3.13% | 0.00% | -61.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -17.22% | 66.45% | 35.24% | 236.75% | -116.13% |
| Change in Net Operating Assets | -260.65% | 257.18% | 3.83% | 32.16% | -110.96% |
| Cash from Operations | -5,658.97% | 97.33% | 10.86% | 6.87% | -124.94% |
| Capital Expenditure | -- | -- | 100.00% | 0.00% | 80.28% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 198.36% | -127.34% | 378.19% | -70.37% | 119.29% |
| Cash from Investing | 198.36% | -127.34% | 379.50% | -70.43% | 119.27% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -88.69% | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -88.69% | -- | -100.00% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -250.94% | 7.01% | 1,913.94% | 142.03% | 83.98% |